OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut microbial metabolite butyrate improves anticancer therapy by regulating intracellular calcium homeostasis
Yibin Che, Guoyu Chen, Qianqian Guo, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 88-102
Closed Access | Times Cited: 46
Yibin Che, Guoyu Chen, Qianqian Guo, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 88-102
Closed Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid
Harry Cheuk-Hay Lau, Xiang Zhang, Fenfen Ji, et al.
EBioMedicine (2024) Vol. 100, pp. 104952-104952
Open Access | Times Cited: 45
Harry Cheuk-Hay Lau, Xiang Zhang, Fenfen Ji, et al.
EBioMedicine (2024) Vol. 100, pp. 104952-104952
Open Access | Times Cited: 45
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 11
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 11
Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases
Eman K. E. Anwer, Muhammad Ajagbe, Mohamed Sherif, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 100-100
Open Access | Times Cited: 1
Eman K. E. Anwer, Muhammad Ajagbe, Mohamed Sherif, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 100-100
Open Access | Times Cited: 1
Latest advancements and trends in biomedical polymers for disease prevention, diagnosis, treatment, and clinical application
Mingxia Jiang, Huapan Fang, Huayu Tian
Journal of Controlled Release (2025) Vol. 380, pp. 138-174
Closed Access | Times Cited: 1
Mingxia Jiang, Huapan Fang, Huayu Tian
Journal of Controlled Release (2025) Vol. 380, pp. 138-174
Closed Access | Times Cited: 1
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives
Xuejiao Wei, Fei Wang, Peng Tan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107148-107148
Open Access | Times Cited: 8
Xuejiao Wei, Fei Wang, Peng Tan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107148-107148
Open Access | Times Cited: 8
Gut microbial metabolites in cancer therapy
Panwei Song, Zhi Peng, Xiaohuan Guo
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 7
Panwei Song, Zhi Peng, Xiaohuan Guo
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 7
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers
Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2372-2372
Open Access | Times Cited: 7
Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2372-2372
Open Access | Times Cited: 7
Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma
Ping Chen, Chengchen Yang, Rende Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Ping Chen, Chengchen Yang, Rende Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches
Lindsey Williams, Shijie Cao
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108605-108605
Closed Access | Times Cited: 5
Lindsey Williams, Shijie Cao
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108605-108605
Closed Access | Times Cited: 5
The causal relationship between gut microbiota and lymphoma: a two-sample Mendelian randomization study
Biyun Li, Yahui Han, Zhiyu Fu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Biyun Li, Yahui Han, Zhiyu Fu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer
Hongyan Gou, Ruijie Zeng, Harry Cheuk-Hay Lau, et al.
Pharmacological Research (2024) Vol. 208, pp. 107373-107373
Open Access | Times Cited: 5
Hongyan Gou, Ruijie Zeng, Harry Cheuk-Hay Lau, et al.
Pharmacological Research (2024) Vol. 208, pp. 107373-107373
Open Access | Times Cited: 5
Decitabine-based nanoparticles for enhanced immunotherapy of hepatocellular carcinoma via DNA hypermethylation reversal
Hongqiao Cai, Xiaocheng Li, Yahui Liu, et al.
Chemical Engineering Journal (2024) Vol. 492, pp. 152175-152175
Closed Access | Times Cited: 4
Hongqiao Cai, Xiaocheng Li, Yahui Liu, et al.
Chemical Engineering Journal (2024) Vol. 492, pp. 152175-152175
Closed Access | Times Cited: 4
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen Chen, Peng Han, Yanping Qing
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103579-103579
Closed Access | Times Cited: 4
Chen Chen, Peng Han, Yanping Qing
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103579-103579
Closed Access | Times Cited: 4
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
Elisa Monti, Clara Vianello, Ilaria Leoni, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 84-84
Open Access
Elisa Monti, Clara Vianello, Ilaria Leoni, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 84-84
Open Access
Lactobacillus gasseri prevents ibrutinib-associated atrial fibrillation through butyrate
Ling Shi, Yu Duan, Ning Fang, et al.
EP Europace (2025)
Closed Access
Ling Shi, Yu Duan, Ning Fang, et al.
EP Europace (2025)
Closed Access
Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment
Wei-Qiang Huang, Tao Jiang, Jiaxuan He, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Wei-Qiang Huang, Tao Jiang, Jiaxuan He, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Lactobacillus johnsonii Generates Cyclo(pro‐trp) and Promotes Intestinal Ca2+ Absorption to Alleviate CKD–SHPT
Xubin Zeng, Lihua Sun, Huichao Xie, et al.
Advanced Science (2025)
Open Access
Xubin Zeng, Lihua Sun, Huichao Xie, et al.
Advanced Science (2025)
Open Access
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Jiaao Sun, Shiyan Song, Jiahua Liu, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
Jiaao Sun, Shiyan Song, Jiahua Liu, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
Mario Romeo, Marcello Dallio, Fiammetta Di Nardo, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 124-124
Open Access
Mario Romeo, Marcello Dallio, Fiammetta Di Nardo, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 124-124
Open Access
Multi-omics assessment of gut microbiota in circadian rhythm disorders: a cross-sectional clinical study
Yuting Tian, Rong Zhao, Song Xiao, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Yuting Tian, Rong Zhao, Song Xiao, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
Mingyao Huang, Quansong Ji, Huiyan Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Mingyao Huang, Quansong Ji, Huiyan Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
